Abstract

BackgroundThe impact of nutritional supplements on weight gain in HIV-infected children on antiretroviral treatment (ART) remains uncertain. Starting supplements depends upon current weight-for-age or other acute malnutrition indicators, producing time-dependent confounding. However, weight-for-age at ART initiation may affect subsequent weight gain, independent of supplement use. Implications for marginal structural models (MSMs) with inverse probability of treatment weights (IPTW) are unclear.MethodsIn the ARROW trial, non-randomised supplement use and weight-for-age were recorded monthly from ART initiation. The effect of supplements on weight-for-age over the first year was estimated using generalised estimating equation MSMs with IPTW, both with and without interaction terms between baseline weight-for-age and time. Separately, data were simulated assuming no supplement effect, with use depending on current weight-for-age, and weight-for-age trajectory depending on baseline weight-for-age to investigate potential bias associated with different MSM specifications.ResultsIn simulations, despite correctly specifying IPTW, omitting an interaction in the MSM between baseline weight-for-age and time produced increasingly biased estimates as associations between baseline weight-for-age and subsequent weight trajectory increased. Estimates were unbiased when the interaction between baseline weight-for-age and time was included, even if the data were simulated with no such interaction. In ARROW, without an interaction the estimated effect was +0.09 (95%CI +0.02,+0.16) greater weight-for-age gain per month’s supplement use; this reduced to +0.03 (-0.04,+0.10) including the interaction.DiscussionThis study highlights a specific situation in which MSM model misspecification can occur and impact the resulting estimate. Since an interaction in the MSM (outcome) model does not bias the estimate of effect if the interaction does not exist, it may be advisable to include such a term when fitting MSMs for repeated measures.

Highlights

  • Ready-to-use therapeutic food, such as plumpy’nut (Nutriset, Rouen, France), is an energydense, peanut-based paste containing sugar, vegetable fat and skimmed milk powder, fortified with vitamins and minerals

  • In ARROW, without an interaction the estimated effect was +0.09 (95%CI +0.02,+0.16) greater weight-for-age gain per month’s supplement use; this reduced to +0.03 (-0.04,+0.10) including the interaction

  • This study highlights a specific situation in which marginal structural models (MSMs) model misspecification can occur and impact the resulting estimate

Read more

Summary

Introduction

Ready-to-use therapeutic food, such as plumpy’nut (Nutriset, Rouen, France), is an energydense, peanut-based paste containing sugar, vegetable fat and skimmed milk powder, fortified with vitamins and minerals. It was designed, and is widely used, for nutritional rehabilitation of children with severe acute malnutrition. If there are further unmeasured common causes of CD4 and mortality, conditioning on CD4 will induce an association between exposure and these unmeasured common causes, introducing further bias [6,7,8] In this application, weight-for-age is both the time-varying confounder and the outcome of interest. The impact of nutritional supplements on weight gain in HIV-infected children on antiretroviral treatment (ART) remains uncertain. Implications for marginal structural models (MSMs) with inverse probability of treatment weights (IPTW) are unclear

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call